286 related articles for article (PubMed ID: 30866602)
1. In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates.
Karamanlıoğlu D; Dizbay M
Turk J Med Sci; 2019 Apr; 49(2):683-686. PubMed ID: 30866602
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
Wang CH; Yu CM; Hsu ST; Wu RX
J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
Chung HS; Hong SG; Kim YR; Shin KS; Whang DH; Ahn JY; Park YJ; Uh Y; Chang CL; Shin JH; Lee HS; Lee K; Chong Y
J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
Lee YL; Liu CE; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2023 Aug; 62(2):106878. PubMed ID: 37285926
[TBL] [Abstract][Full Text] [Related]
8. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
[No Abstract] [Full Text] [Related]
9. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
[TBL] [Abstract][Full Text] [Related]
10. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
[TBL] [Abstract][Full Text] [Related]
11. Effect of antimicrobials on
Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
[No Abstract] [Full Text] [Related]
12. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.
Church D; Lloyd T; Peirano G; Pitout J
Scand J Infect Dis; 2013 Apr; 45(4):265-70. PubMed ID: 23113657
[TBL] [Abstract][Full Text] [Related]
14. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
Wei C; Ni W; Cai X; Cui J
Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital.
Chung HS; Hong SG; Lee Y; Kim M; Yong D; Jeong SH; Lee K; Chong Y
Yonsei Med J; 2012 Mar; 53(2):439-41. PubMed ID: 22318836
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections.
Farrell DJ; Sader HS; Jones RN
Antimicrob Agents Chemother; 2010 Jun; 54(6):2735-7. PubMed ID: 20368399
[TBL] [Abstract][Full Text] [Related]
17. Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.
Betts JW; Phee LM; Woodford N; Wareham DW
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1565-72. PubMed ID: 24781003
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
Çıkman A; Parlak M; Bayram Y; Güdücüoğlu H; Berktaş M
Afr Health Sci; 2016 Mar; 16(1):149-52. PubMed ID: 27358626
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections.
Tekçe YT; Erbay A; Cabadak H; Sen S
J Chemother; 2012 Jun; 24(3):150-4. PubMed ID: 22759759
[TBL] [Abstract][Full Text] [Related]
20. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
Wu RX; Yu CM; Hsu ST; Wang CH
J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]